Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Repatha Syringe

Evolocumab

Open in the dashboard

Part D claims

126,019

Prescriptions dispensed, refills included

Drug cost

$94,361,236

Paid at the pharmacy, in all

Prescribers

6,732

With 11 or more claims of it

In 2024, Medicare Part D recorded 126,019 claims for Repatha Syringe (evolocumab) from 6,732 prescribers, at a total drug cost of $94.4 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Repatha Syringe by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
FL 784 15,372 $12,285,310
CA 588 11,310 $8,693,740
TX 548 10,539 $8,305,742
NY 444 8,235 $6,374,965
PA 285 5,361 $3,635,809
MI 272 5,211 $4,262,854
OH 258 4,870 $3,372,382
GA 244 4,500 $3,452,080
IL 224 4,286 $2,925,420
TN 224 4,230 $3,021,147
KY 210 4,211 $2,982,122
NC 218 3,748 $2,722,157
MO 191 3,569 $2,500,767
AZ 161 3,220 $2,692,365
NJ 118 2,173 $1,875,133
The other 38 states and territories
State Prescribers Claims Drug cost
VA 129 2,105 $1,473,715
LA 124 2,072 $1,327,379
AL 111 2,026 $1,415,510
IN 111 1,975 $1,409,126
SC 111 1,853 $1,372,074
MA 85 1,629 $1,360,503
WA 75 1,549 $1,134,615
CO 88 1,511 $1,082,890
NV 78 1,505 $1,319,963
WI 74 1,462 $967,039
MD 73 1,408 $1,212,928
OK 70 1,379 $1,024,217
PR 63 1,285 $745,215
KS 77 1,227 $838,314
AR 68 1,158 $731,149
IA 52 1,098 $667,033
CT 58 1,000 $752,816
MS 54 952 $711,239
UT 57 918 $648,131
WV 49 879 $609,636
OR 41 695 $518,598
ID 31 593 $394,858
NE 35 578 $340,580
SD 30 566 $352,242
MN 34 516 $350,640
ND 26 483 $348,077
NM 21 458 $324,951
NH 27 450 $379,771
MT 27 446 $352,456
ME 24 365 $262,984
DE 14 272 $253,137
WY 11 185 $113,997
RI 9 172 $136,577
VT 9 144 $101,359
HI 6 97 $76,039
DC 7 93 $85,649
AK 3 64 $50,854
XX 1 16 $12,984

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 41
Part D claims for Repatha Syringe by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Cardiology 2,103 43,314 $34,861,078
Internal Medicine 1,315 23,933 $17,281,333
Family Practice 1,044 17,390 $11,611,540
Nurse Practitioner 962 16,667 $11,855,696
Interventional Cardiology 583 11,828 $9,354,862
Physician Assistant 318 5,218 $3,741,065
Endocrinology 145 2,726 $2,171,356
General Practice 58 1,107 $848,657
Advanced Heart Failure and Transplant Cardiology 33 673 $520,168
Clinical Cardiac Electrophysiology 32 587 $415,907
Nephrology 24 388 $256,405
Geriatric Medicine 15 277 $180,636
Neurology 14 212 $148,664
Certified Clinical Nurse Specialist 10 203 $158,336
Hospitalist 11 193 $115,700

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Ildefonso Mas Cardiology FL 216 $80,368 None on record
Rosalie Alcantara Nurse Practitioner CA 147 $79,890 $123
Chinh Mai Internal Medicine CA 143 $61,387 $10
James Rice Cardiology MO 134 $82,068 $158
Mauricio Melhado Cardiology FL 133 $135,545 $191

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for evolocumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record